Journal of addiction medicine · 2025
Trends and Predictors of Prescription Drug Substance Use Disorders in the United States: The Role of Recovery Capital.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Koga Mayu, Coulombe Simon, Tanaka Hideaki, Saatcioğlu Onur Can, Sahker Ethan
Аннотация
OBJECTIVES: To examine trends and predictors of prescription drug substance use disorders (RxSUDs), highlighting risk and protective factors, with a particular focus on patient recovery capital (social factors known to protect against SUDs) for strengthening policy and practice guidelines.
METHODS: This retrospective cross-sectional study used National Survey on Drug Use and Health (NSDUH) data to assess individuals with RxSUDs between 2016 and 2022. RxSUDs include opioid, sedative, hypnotic, anxiolytic, stimulant, or tranquilizer use disorders. Trends were assessed using time-series logistic regression. Demographic, recovery capital, access, and screening characteristics were investigated as RxSUD predictors using cross-sectional multivariate modeling.
RESULTS: The sample (survey n = 292,505; weighted n = 250,414,772) was mostly female (52%), White (63%), and aged 35-49 (25%). Time-series analysis (2016-2020) showed no change in RxSUD prevalence (OR = 0.96, 95% CI = 0.91-1.01). Age showed a clinically meaningful association with older adults being less likely to report RxSUDs (OR = 0.43, 95% CI = 0.31-0.59). Recovery capital strengths showed large clinically meaningful odds predicting RxSUD in 6 of 6 variables (OR >2.0). Healthcare provider substance use screening was associated with lower odds of RxSUDs (OR = 0.39, 95% CI = 0.12, 1.27).
CONCLUSIONS: Recovery capital reduces the odds of an RxSUD, adjusting for demographics, access, and screening variables. In addition, patient access and healthcare provider drug use screening are important factors to consider in clinical assessment and health care policies aimed at reducing RxSUDs. Improving recovery capital requires targeted policies addressing individual and community needs and can have far-reaching outcomes as they can improve constituencies' wellbeing in addition to RxSUD liability.
METHODS: This retrospective cross-sectional study used National Survey on Drug Use and Health (NSDUH) data to assess individuals with RxSUDs between 2016 and 2022. RxSUDs include opioid, sedative, hypnotic, anxiolytic, stimulant, or tranquilizer use disorders. Trends were assessed using time-series logistic regression. Demographic, recovery capital, access, and screening characteristics were investigated as RxSUD predictors using cross-sectional multivariate modeling.
RESULTS: The sample (survey n = 292,505; weighted n = 250,414,772) was mostly female (52%), White (63%), and aged 35-49 (25%). Time-series analysis (2016-2020) showed no change in RxSUD prevalence (OR = 0.96, 95% CI = 0.91-1.01). Age showed a clinically meaningful association with older adults being less likely to report RxSUDs (OR = 0.43, 95% CI = 0.31-0.59). Recovery capital strengths showed large clinically meaningful odds predicting RxSUD in 6 of 6 variables (OR >2.0). Healthcare provider substance use screening was associated with lower odds of RxSUDs (OR = 0.39, 95% CI = 0.12, 1.27).
CONCLUSIONS: Recovery capital reduces the odds of an RxSUD, adjusting for demographics, access, and screening variables. In addition, patient access and healthcare provider drug use screening are important factors to consider in clinical assessment and health care policies aimed at reducing RxSUDs. Improving recovery capital requires targeted policies addressing individual and community needs and can have far-reaching outcomes as they can improve constituencies' wellbeing in addition to RxSUD liability.